SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
LeMaitre Vascular issued a press release on August 4, 2026 disclosing preliminary Q2 2026 financial results, including net sales of $70.4mm (+10%), gross margin of 72.1%, operating income of $20.4mm (+26%), and diluted EPS of $0.74 (+23%), along with forward guidance for Q3, Q4, and full-year 2026. The filing includes condensed consolidated financial statements and is a classic Item 2.02 earnings disclosure.
View raw filing on EDGAR →Hecla Mining Company disclosed second quarter 2026 financial and operating results, reporting revenue of $334 million, income from continuing operations of $118 million ($0.18 per share), and adjusted EBITDA of $199 million, with detailed operational metrics across all producing assets.
View raw filing on EDGAR →Talos Energy disclosed Q2 2026 financial and operational results, reporting net income of $149.7 million ($0.88 per diluted share) and adjusted EBITDA of $402.4 million, along with revised full-year 2026 guidance and production metrics.
View raw filing on EDGAR →This is a press release dated August 4, 2026, announcing Horizon Quantum's second quarter 2026 financial results for the period ended June 30, 2026. The exhibit discloses Q2 2026 operating loss of $7.2 million, net loss of $115.2 million (including a $108.3 million non-cash warrant derivative loss), cash position of $113.3 million, and operational highlights including product releases (Beryllium programming language) and strategic collaborations. The disclosure includes condensed consolidated balance sheet data and detailed financial metrics, making it a standard quarterly earnings announcement material to investors.
View raw filing on EDGAR →RYTHM, Inc. issued a press release on August 4, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $23.0 million (up 73% sequentially), net income of $1.2 million, and adjusted EBITDA of $6.4 million. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The results show material operational improvement and are clearly intended to inform investors of the company's financial performance.
View raw filing on EDGAR →The filing discloses an announcement of financial results for Q2 2026 (ended June 30, 2026) to be released on August 14, 2026, along with an operations update and conference call. Although this is technically a notice of a forthcoming earnings announcement rather than the results themselves, the press release explicitly states the Company "plans to announce its financial results for the second quarter ended June 30, 2026" and will "provide an update on its operations," which constitutes a material earnings-related disclosure under Item 7.01 (Regulation FD Disclosure). The materiality is high as earnings announcements are core investor information.
View raw filing on EDGAR →This is a clear earnings release for Tigo Energy's second quarter 2026 results, filed on August 4, 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release discloses Q2 2026 revenue of $25.4 million (up 5.6% YoY), GAAP net income of $2.2 million, adjusted EBITDA of $52 thousand, and provides Q3 and full-year 2026 guidance. The filing explicitly states the press release is furnished as Exhibit 99.1 and includes management commentary, financial highlights, and forward-looking statements typical of quarterly earnings disclosures.
View raw filing on EDGAR →This is a press release announcing Jin Medical's unaudited financial results for the six months ended March 31, 2026. The document discloses total revenue of $8.9 million (down 9.7% YoY), gross margin of 26.9%, and a net loss of $0.2 million. As a results announcement for an interim period, this is an earnings_release. The disclosure is material because it reports financial performance, identifies operational challenges (foreign exchange pressure, loss of electric scooter sales), and provides management commentary on the company's financial position and outlook.
View raw filing on EDGAR →TransDigm Group issued a press release on August 4, 2026 announcing financial results for its third quarter ended June 27, 2026, including net sales of $2,741 million (up 23%), net income of $540 million (up 10%), and adjusted EPS of $10.87 (up 13%), along with upward revision to fiscal 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Westlake Corporation issued a press release on August 4, 2026, announcing its second quarter 2026 financial results, including net sales of $3.3 billion, net income of $260 million ($2.01 per share), and EBITDA of $679 million, with detailed segment performance and year-over-year comparisons.
View raw filing on EDGAR →Assurant issued a news release on August 4, 2026 announcing financial results for the quarter ended June 30, 2026, with detailed GAAP and adjusted financial metrics (net income, EBITDA, EPS), segment performance, and updated 2026 full-year outlook. This is a standard quarterly earnings release disclosed under Item 2.02 and attached as Exhibit 99.1.
View raw filing on EDGAR →This is a standard earnings release disclosing quarterly and six-month financial results for the periods ended June 30, 2026. The filing explicitly states "On August 4, 2026, the Company reported its financial results for the three and six months ended June 30, 2026" with a press release furnished as Exhibit 99.1. The press release presents revenue ($19.9M for Q2 2026, up 16% YoY), net loss ($3.2M for Q2 2026, down 28% YoY), adjusted EBITDA, and updated full-year guidance ($72-75M), all material metrics for investor assessment.
View raw filing on EDGAR →Energy Transfer LP issued a press release on August 4, 2026 announcing its financial and operating results for the second quarter ended June 30, 2026, including net income of $2.09 billion, Adjusted EBITDA of $5.07 billion (31% increase year-over-year), and updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →This is a preliminary guidance announcement for Q3 2026 (quarter ended July 31, 2026) disclosing expected record revenue ($195.0–$200.0M), gross profit ($51.0–$53.5M), and Adjusted EBITDA ($15.2–$16.5M), all exceeding analyst consensus expectations. Although labeled "guidance" rather than final results, it functions as an earnings disclosure announcing anticipated quarterly financial performance ahead of the full results release on September 14, 2026. The guidance is material to investors as it signals significant year-over-year growth (30–34% revenue, 27–33% gross profit, 43–55% Adjusted EBITDA) and operational strength in both Canadian retail and German medical cannabis distribution.
View raw filing on EDGAR →Grown Rogue disclosed unaudited financial results for Q2 and H1 2026, reporting revenue of $11.3 million (41% YoY growth) and Adjusted EBITDA of $2.1 million, along with updated guidance for 2026 and 2027.
View raw filing on EDGAR →This Item 2.02 disclosure furnishes Mosaic's second quarter 2026 earnings announcement as a press release (Exhibit 99.1), reporting net loss of $273 million, adjusted EBITDA of $407 million, and diluted loss per share of $0.86. The filing explicitly states the announcement covers "earnings and results of operations for the quarter ended June 30, 2026," which is the hallmark of an earnings release disclosure.
View raw filing on EDGAR →This exhibit is an earnings release announcing Q2 2026 and first-half 2026 financial results for Pampa Energía. The document discloses consolidated sales of US$746 million in Q2 26 (up 53% year-on-year), adjusted EBITDA of US$415 million (up 75%), and net income of US$172 million (4.3x Q2 25), along with detailed segment breakdowns and operational metrics. While the release also mentions material strategic events (urea project, RIGI approvals), the primary disclosure is the periodic financial results announcement, which is material to investors assessing the company's financial performance and operational trajectory.
View raw filing on EDGAR →Celanese Corporation issued a press release on August 4, 2026, reporting second quarter 2026 financial results, including diluted EPS of $1.15, adjusted EPS of $2.45, and net sales of $2.8 billion. The press release is attached as Exhibit 99.1 and incorporated into Item 2.02 disclosure. This is a standard quarterly earnings release with detailed segment performance, cash flow, and forward guidance.
View raw filing on EDGAR →The Item 7.01 disclosure announces that Scott A. Richardson, President and CEO, will present the Company's "financial results for its second quarter 2026" via webcast on August 5, 2026. The filing includes prepared remarks and slide presentations (Exhibits 99.1(a) and 99.1(b)) and a Non-GAAP reconciliation document (Exhibit 99.2) that explicitly references quarterly financial results and performance metrics. This is a classic earnings release disclosure, even though filed under Item 7.01 (Regulation FD) rather than Item 2.02, and is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →ImmunityBio disclosed quarterly and first-half 2026 financial results via press release attached as Exhibit 99.1, including net product revenue of $50.7 million (Q2 2026, up 92% YoY) and $94.8 million (H1 2026, up 121% YoY), along with detailed consolidated statements of operations, balance sheet data, and cash flow summaries. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →eHealth issued a press release on August 4, 2026 announcing financial results for Q2 and six months ended June 30, 2026, including revenue, net income, adjusted EBITDA, and operating cash flow metrics, along with full-year 2026 guidance. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly discloses "Results of Operations and Financial Condition," which is the standard Item for earnings releases.
View raw filing on EDGAR →Equitable Holdings issued a press release on August 4, 2026 announcing Q2 2026 financial results, disclosing a net loss of $453 million ($1.68 per share) and Non-GAAP operating earnings of $488 million ($1.70 per share), along with business segment performance metrics.
View raw filing on EDGAR →This is a press release announcing Ternium's second quarter and first half 2026 financial results, including consolidated net sales of $4.34 billion, adjusted EBITDA of $717 million, and net income of $465 million. The document explicitly states "This report contains Ternium S.A.'s press release announcing second quarter and first half of 2026 results" and presents detailed financial statements, segment performance, and forward guidance—all hallmarks of a quarterly earnings release material to investors.
View raw filing on EDGAR →Primoris Services Corp disclosed Q2 2026 financial results (quarter ended June 30, 2026) showing revenue of $1,688.2 million (down 10.7% year-over-year), net loss of $24.2 million, and Adjusted EBITDA of $11.4 million (down 92.6% year-over-year), with detailed segment results and forward guidance reflecting material challenges in the Energy segment's renewable projects.
View raw filing on EDGAR →Allegiant Travel Company disclosed second quarter 2026 financial results, reporting consolidated total operating revenue of $943.5M and adjusted diluted earnings per share of $2.19 (up 78.0% year-over-year), along with full-year 2026 guidance of adjusted EPS greater than $6.00.
View raw filing on EDGAR →Douglas Emmett Inc. disclosed its Q2 2026 financial results on August 4, 2026, by posting its "Second Quarter 2026 Earnings Results and Operating Information package" to its website (Exhibit 99.1). The filing includes consolidated operating results, balance sheets, FFO and AFFO metrics, and updated 2026 guidance. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Broadridge disclosed financial results for the fourth quarter and fiscal year ended June 30, 2026, including detailed revenue, operating income, and EPS metrics, along with forward guidance for fiscal 2027.
View raw filing on EDGAR →This is a press release announcing preliminary unaudited financial results for Q2 2026 (ended June 30, 2026), dated August 4, 2026. The document discloses revenue of $7.5 million, net loss of $9.8 million, and diluted loss per ADS of ($0.65), along with detailed financial statements and management commentary. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →Greenlight Capital Re disclosed financial results for Q2 and six months ended June 30, 2026, including gross premiums written, net premiums earned, underwriting results, investment results, net income/loss per share, and book value per share.
View raw filing on EDGAR →Niagen Bioscience issued a press release announcing Q2 2026 earnings for the quarter ended June 30, 2026, reporting net sales of $29.8 million, net income of $1.0 million, and adjusted EBITDA of $3.0 million, along with operational highlights including new product launches and pharmaceutical program developments.
View raw filing on EDGAR →American Well Corporation announced its financial results for the fiscal quarter ended June 30, 2026, on August 4, 2026. The disclosure includes quarterly revenue of $52.0 million, net loss of ($9.6) million, gross margin of 53%, and adjusted EBITDA of ($1.2) million, along with updated full-year 2026 revenue guidance ($200–$205 million) and adjusted EBITDA guidance ($9–$7 million). The earnings report is furnished as Exhibit 99.1 and is typical of Item 2.02 earnings releases. This is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →OPENLANE issued a press release on August 4, 2026 announcing its financial results for the three and six months ended June 30, 2026, including revenue of $555 million (15% YoY growth), net income of $44 million (33% YoY growth), and Adjusted EBITDA of $103 million (19% YoY growth). The company also raised its 2026 consolidated Adjusted EBITDA guidance from $365-$385 million to $385-$400 million. The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →This is a standard earnings release disclosing Graphic Packaging's second quarter 2026 financial results, including net sales of $2,188 million, net income of $24 million, and adjusted EBITDA of $247 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing also includes updated 2026 guidance and discussion of operational performance.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 disclosing financial results and operating highlights. The filing explicitly states "On August 4, 2026, Intrepid Potash, Inc. issued a press release announcing its financial results and operating highlights for the second quarter of 2026" with the press release furnished as Exhibit 99.1. The disclosure includes key financial metrics (sales, gross margin, net income, EBITDA), segment performance, production guidance updates, and capital allocation decisions—all hallmarks of an earnings release under Item 2.02.
View raw filing on EDGAR →OrthoPediatrics issued a press release on August 4, 2026, announcing its Q2 2026 financial results, including record revenue of $70.5 million (up 15% YoY), record adjusted EBITDA of $6.8 million, and increased full-year 2026 guidance to $265.0–$269.0 million. The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes unaudited condensed consolidated financial statements and detailed segment performance metrics.
View raw filing on EDGAR →Hamilton Lane Incorporated disclosed its financial results for the first fiscal quarter ended June 30, 2026, via press release and detailed presentation furnished as Exhibit 99.1. The filing reports GAAP net income of $124.9 million (up 62% YoY), net income attributable to Hamilton Lane of $80.5 million (up 50% YoY), and diluted EPS of $1.93 (up 51% YoY), along with comprehensive financial statements and business metrics. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →Superior Group of Companies announced second quarter 2026 financial results, reporting net sales of $147.8 million, net income of $1.2 million, and adjusted EBITDA of $7.7 million, along with full-year 2026 guidance and a quarterly dividend declaration.
View raw filing on EDGAR →This is a clear earnings release disclosing Q2 2026 financial results for Turning Point Brands, Inc. The Item 2.02 filing announces consolidated net sales of $142.9 million (up 22.6%), net income of $3.6 million (down 75.2%), and includes detailed segment performance, balance sheet, and cash flow statements. The company also raised full-year Modern Oral guidance. The press release is attached as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release disclosing Chatham Lodging Trust's second quarter 2026 financial results. The press release (Exhibit 99.1) announces key operating metrics including RevPAR growth of 3%, net income of $6.2 million, AFFO per share of $0.48 (up 22%), and updated 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →The Item 2.02 disclosure announces Lattice Semiconductor's financial results for Q2 2026 (quarter ended July 4, 2026) via a press release furnished as Exhibit 99.1. The press release reports record revenue of $201.1 million (up 62% YOY), GAAP net income of $0.14 per diluted share, and non-GAAP EPS of $0.53 (up more than 120% YOY), along with forward guidance for Q3 2026. This is a standard quarterly earnings release disclosure material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →This is a clear earnings release disclosing quarterly financial results for the period ended June 30, 2026. The filing explicitly states "On July 30, 2026, Horizon Technology Finance Corporation (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2026" and includes detailed operating results, net investment income per share ($0.11), NAV per share ($6.23), portfolio yield (14.9%), and other material financial metrics. The press release is attached as Exhibit 99.1 and constitutes a standard Item 2.02 earnings disclosure.
View raw filing on EDGAR →PAMT CORP disclosed Q2 2026 financial results via press release dated August 4, 2026, reporting total revenues of $164.7 million (up 8.9% YoY), operating loss of $10.4 million, and net loss of $7.4 million ($0.36 diluted loss per share).
View raw filing on EDGAR →This Item 2.02 disclosure announces Fuel Tech's financial results for the fiscal quarter ended June 30, 2026, with a press release furnished as Exhibit 99.1. The filing reports Q2 2026 revenues of $6.5 million (up 17% YoY), net loss of $(1.2) million, and segment performance details. This is a standard quarterly earnings release that would materially affect a reasonable investor's assessment of the company's financial condition and operating performance.
View raw filing on EDGAR →This is a clear earnings release disclosing Travere Therapeutics' second quarter 2026 financial results. The filing explicitly states "Travere Therapeutics Reports Second Quarter 2026 Financial Results" and discloses key metrics including U.S. net product sales of $161.4 million (up from $94.8 million YoY), FILSPARI sales of $141.1 million (96% YoY growth), R&D and SG&A expenses, and net loss of $34.8 million. The press release is attached as Exhibit 99.1 and covers both financial results and material corporate updates including FDA approval of FILSPARI for FSGS and the in-licensing of civorebrutinib.
View raw filing on EDGAR →Workiva issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $255 million (up 19% year-over-year), GAAP net income of $13 million (versus a loss of $19 million in the prior year), and non-GAAP operating margin of 16.8% (up from 3.8%). The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release disclosing Otter Tail Corporation's consolidated financial results for the second quarter of 2026, issued on August 3, 2026. The press release reports quarterly diluted loss per share of $0.18 and adjusted diluted earnings per share of $1.66, updates annual EPS guidance to $3.84–$4.24, and provides detailed segment performance and 2026 outlook. The Item 2.02 disclosure explicitly states the press release is furnished as Exhibit 99.1, which is the standard format for earnings releases in 8-K filings.
View raw filing on EDGAR →The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing financial results for the quarter ended June 30, 2026. The filing includes detailed quarterly and six-month financial statements showing net losses, revenue, and operating expenses, along with a corporate update on clinical development programs. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →The filing discloses NextBoat Inc.'s announcement of its second quarter 2026 financial and operating results to be released on August 13, 2026, followed by an earnings conference call. Although this is technically an announcement of a future earnings release rather than the results themselves, the 8-K Item 7.01 disclosure and attached press release (Exhibit 99.1) center on the scheduled earnings announcement, which is a material event affecting investor information about the company's financial performance.
View raw filing on EDGAR →The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing Q2 2026 financial results for the quarter ended June 30, 2026. The press release includes key financial metrics (commission income, net loss, AEBITDA, balance sheet items) and a business update on AI platform development. This is a standard earnings release disclosure.
View raw filing on EDGAR →Pinterest announced its Q2 2026 financial results on August 4, 2026, disclosing revenue of $1,180 million (18% growth), net loss of $47 million, Adjusted EBITDA of $311 million, and record 640 million monthly active users. The press release is attached as Exhibit 99.1 and includes forward guidance for Q3 2026. This is a standard quarterly earnings release filed under Item 2.02.
View raw filing on EDGAR →